New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 31, 2019 - Sandoz launched an AO-rated generic version of AstraZeneca’s Faslodex (fulvestrant) injection.
Download PDF
Return to publications
